Stocklytics Platform
Asset logo for symbol HUM
Humana
HUM59
$357.85arrow_drop_down1.99%-$7.28
S&P500
Asset logo for symbol HUM
HUM59

$357.85

arrow_drop_down1.99%
Key Stats
Open$367.92
Prev. Close$365.14
EPS14.20
Next Earnings DateJan 24, 2025
LOWHIGH
Day Range357.17
369.17
52 Week Range298.60
530.53
Ratios
Revenue-
EPS14.20
Fundamentals
Industry average yield2.87%
Last Dividend pay dateOct 25, 2024

Stock Analysis

Technicals

Summarizing what the indicators are suggesting.

Strong Buy
Buy
Neutral
Sell
Strong Sell

Analyst rating

An aggregate view of professional's ratings.

Strong Buy
Buy
Neutral
Sell
Strong Sell

Stock Performance

HUMarrow_drop_down1.64%
US Healthcare Sectorarrow_drop_down0.49%
US Marketarrow_drop_down2.11%
check_circle

HUM / Market

HUM exceeded the US Market which returned -2.11% over the last twenty four hours.
warning

HUM / Healthcare Sector

HUM lose to the US Healthcare sector which returned -0.49% over the last twenty four hours.

Humana (HUM) Statistics

Humana Inc, commonly known as Humana, is a leading healthcare company headquartered in Louisville, Kentucky. As of the latest available data, Humana Inc has a market capitalization of $45.6 billion. The stock, listed under the ticker symbol HUM, is a component of the S&P 500 index. In terms of valuation metrics, Humana Inc has a price-to-earnings ratio of 15.6 and a price-to-sales ratio of 0.77. These metrics indicate that the stock is reasonably valued in relation to its earnings and revenue. In terms of fundamentals, Humana Inc has a strong balance sheet with a total debt of $12.3 billion and a gross profit of $19.4 billion. The company also has a healthy profit margin of 8.5% and generates a revenue per share of $303.55.
In terms of stock performance, Humana Inc has outperformed its sector over the past year. While the sector saw a decline of 5%, Humana Inc's stock gained 10%, reflecting the company's strong performance and market position. The CEO of Humana Inc is Bruce D. Broussard, who has been leading the company since 2013. Under his leadership, Humana Inc has experienced significant growth and expansion, delivering value to its shareholders and customers. Overall, Humana Inc is a well-established healthcare company with solid financials and a strong market position, making it an attractive investment option in the healthcare sector.
add Humana  to watchlist

Keep an eye on Humana

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

How has Humana (HUM) stock's performance compared to its sector and the market over the past year?

Over the past year, Humana (HUM) has experienced a price change of . Compared to the Healthcare sector, which saw a change of 25.97%, Humana has underperformed compared to its sector, indicating its relative standing within the Healthcare sector. Against the broader market's change of 58.78%, it has fallen short of the market average. This comparison highlights Humana 's performance relative to both its sector and the overall market over the last year.
help

What is the PE ratio of Humana (HUM) stock?

The PE (Price to Earnings) ratio of Humana (HUM) is currently 25.2. This metric is used to evaluate the valuation of a company's stock, comparing its current share price relative to its per-share earnings.
help

What is the EPS of Humana (HUM) stock?

The Earnings Per Share (EPS) for Humana (HUM), calculated on a diluted basis, is $14.2. EPS is a key indicator of a company's profitability, showing the portion of a company's profit allocated to each outstanding share of common stock.
help

What is the operating margin of Humana (HUM) stock?

The operating margin for Humana (HUM) is 4.09%. This metric represents the percentage of revenue that remains after paying for variable production costs, indicating the efficiency and profitability of the company's core business operations.
help

What is the EBITDA of Humana (HUM) stock?

The EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) of Humana (HUM) is $4.26B. EBITDA is a widely used earnings metric to assess a company's operational efficiency and profitability before the impact of non-operating decisions such as financing, accounting, and tax environments.
help

How much debt does Humana (HUM) have?

Humana (HUM) has a total debt of $13.27B. The net debt, which accounts for cash and cash equivalents against the total debt, is $7.39B.

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Take Your Investments to a Whole New Level

Stocklytics Platform

© 2024 Stocklytics.com All rights reserved.

Stocklytics.com is not a financial advisor, and all data and information provided on this website are for informational purposes only. The content on Stocklytics.com is not intended to be a substitute for professional financial advice. Investors should conduct their own research and consult with a qualified financial advisor before making any investment decisions. Stocklytics.com makes no representations or warranties regarding the accuracy, completeness, or suitability of any information provided and is not liable for any errors or omissions, or for any losses incurred as a result of reliance on the information provided on this website.

Stocklytics Discord public channelStocklytics X Social Media